Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Verhaeghe

Showing results (71-80 of 75) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 75 results.
ACS Medicinal Chemistry Letters|January 19, 2019
Nongenotoxic 3-Nitroimidazo[1,2-<i>a</i>]pyridines Are NTR1 Substrates That Display Potent <i>in Vitro</i> Antileishmanial ActivityCyril Fersing, Louise Basmaciyan, Clotilde Boudot, et al.
ACS Medicinal Chemistry Letters|April 16, 2020
New 8-Nitroquinolinone Derivative Displaying Submicromolar <i>in Vitro</i> Activities against Both <i>Trypanosoma brucei</i> and <i>cruzi</i>Julien Pedron, Clotilde Boudot, Jean-Yves Brossas, et al.
European Journal of Medicinal Chemistry|August 16, 2020
Antikinetoplastid SAR study in 3-nitroimidazopyridine series: Identification of a novel non-genotoxic and potent anti-T. b. brucei hit-compound with improved pharmacokinetic propertiesCyril Fersing, Clotilde Boudot, Romain Paoli-Lombardo, et al.
European Journal of Medicinal Chemistry|July 12, 2020
8-Alkynyl-3-nitroimidazopyridines display potent antitrypanosomal activity against both T. b. brucei and cruziCyril Fersing, Clotilde Boudot, Caroline Castera-Ducros, et al.
Microbiology Spectrum|November 2, 2021
A New Thienopyrimidinone Chemotype Shows Multistage Activity against Plasmodium falciparum, Including Artemisinin-Resistant ParasitesHenriette Bosson-Vanga, Nicolas Primas, Jean-François Franetich, et al.
Pageof 8

Showing results (71-80 of 75) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 75 results.
ACS Medicinal Chemistry Letters|January 19, 2019
Nongenotoxic 3-Nitroimidazo[1,2-<i>a</i>]pyridines Are NTR1 Substrates That Display Potent <i>in Vitro</i> Antileishmanial ActivityCyril Fersing, Louise Basmaciyan, Clotilde Boudot, et al.
ACS Medicinal Chemistry Letters|April 16, 2020
New 8-Nitroquinolinone Derivative Displaying Submicromolar <i>in Vitro</i> Activities against Both <i>Trypanosoma brucei</i> and <i>cruzi</i>Julien Pedron, Clotilde Boudot, Jean-Yves Brossas, et al.
European Journal of Medicinal Chemistry|August 16, 2020
Antikinetoplastid SAR study in 3-nitroimidazopyridine series: Identification of a novel non-genotoxic and potent anti-T. b. brucei hit-compound with improved pharmacokinetic propertiesCyril Fersing, Clotilde Boudot, Romain Paoli-Lombardo, et al.
European Journal of Medicinal Chemistry|July 12, 2020
8-Alkynyl-3-nitroimidazopyridines display potent antitrypanosomal activity against both T. b. brucei and cruziCyril Fersing, Clotilde Boudot, Caroline Castera-Ducros, et al.
Microbiology Spectrum|November 2, 2021
A New Thienopyrimidinone Chemotype Shows Multistage Activity against Plasmodium falciparum, Including Artemisinin-Resistant ParasitesHenriette Bosson-Vanga, Nicolas Primas, Jean-François Franetich, et al.
Pageof 8